×
About 1,675 results

ALLMedicine™ Insulinoma Center

Research & Reviews  642 results

Challenge of coexisting type 2 diabetes mellitus and insulinoma: a case report.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479877
Journal of Medical Case Reports; Singbo J, Locketz M et. al.

Sep 30th, 2021 - Insulinomas are rare clinical entities, but concurrent diabetes mellitus is even more uncommon, and the combination is easily missed. Recurrent hypoglycemia could be misconstrued as improved glycemic control. We present an unusual patient with typ...

Could the burden of pancreatic cancer originate in childhood?
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409163
World Journal of Gastroenterology; Diaconescu S, Gîlcă-Blanariu GE et. al.

Sep 21st, 2021 - The presence of pancreatic cancer during childhood is extremely rare, and physicians may be tempted to overlook this diagnosis based on age criteria. However, there are primary malignant pancreatic tumors encountered in pediatric patients, such as...

TRIB3 regulates FSHR expression in human granulosa cells under high levels of free fatt...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428109
Reproductive Biology and Endocrinology : RB&E; Wang N, Si C et. al.

Sep 11th, 2021 - Granulosa cells (GCs) in cumulus oophorus highly express follicle stimulating hormone receptor (FSHR), which is the most important mediator of both estradiol synthesis and oocyte maturation. Obese women have elevated free fatty acids (FFAs) levels...

68Ga-Exendin-4 PET/CT Differentiates Insulinoma From Accessory Spleen in a Patient Pres...
https://doi.org/10.1097/RLU.0000000000003895
Clinical Nuclear Medicine; Pang Y, Meng T et. al.

Sep 11th, 2021 - A 55-year-old woman with endogenous hyperinsulinemia hypoglycemia was clinically diagnosed with insulinoma. Contrast-enhanced MRI revealed an inconclusive hypointense lesion in the pancreatic tail, and the enhancement pattern does not support the ...

68 Ga-DOTATATE PET/CT imaging in endogenous hyperinsulinemic hypoglycemia: A tertiary e...
https://doi.org/10.1111/cen.14586
Clinical Endocrinology; Shah R, Sehemby M et. al.

Sep 10th, 2021 - Literature regarding utility of 68 Ga-DOTATATE PET/CT in insulinoma localization across various subgroups [benign/malignant/multiple endocrine neoplasia-1 (MEN-1) syndrome associated] remains scarce. In this study, the performance of 68 Ga-DOTATAT...

see more →

Clinicaltrials.gov  5 results

[68Ga]Ga-HBED-CC-exendin-4 and [68Ga]Ga-NOTA-exendin-4 PET/CT Imaging in the Same Group of Insulinoma Patients
https://clinicaltrials.gov/ct2/show/NCT05034783

Sep 5th, 2021 - Insulinoma is the most common cause of endogenous hyperinsulinemic hypoglycemia in adult patients without diabetes. The only curative treatment of an insulinoma is its surgical removal. Therefore, exact preoperative localization of the insulinoma ...

Fluorodopa F 18 in Congenital Hyperinsulinism and Insulinoma
https://clinicaltrials.gov/ct2/show/NCT02021604

Jan 30th, 2020 - Congenital Hyperinsulinism (HI) is a disorder of insulin secretion that causes profound hypoglycemia leading to significant morbidity. It is the most common form of persistent neonatal hypoglycemia, and the most dangerous. Inappropriate insulin se...

Application of Raw Corn Starch on Patients With Insulinoma
https://clinicaltrials.gov/ct2/show/NCT03930368

Apr 29th, 2019 - Insulinoma is a rare disease which can cause recurrent hyperinsulinemic hypoglycemia, subsequent hyperphagia as well as weight gain. As only 50% ~ 60% of pharmacological therapy (diazoxide, somatostatin, etc) is effective to elevate blood glucose,...

Whole Body 111In-exendin-4 Imaging Study in Insulinoma Patients
https://clinicaltrials.gov/ct2/show/NCT00937079

Jan 9th, 2015 - Insulinomas arise from pancreatic cells and are the most frequent hormone-active tumours of the pancreas. Insulinomas produce insulin and can become life threatening if they cannot be localised and removed surgically. Complete tumour resection cur...

Laparoscopy to Remove Pancreatic Tumors (Insulinomas)
https://clinicaltrials.gov/ct2/show/NCT00005910

Mar 4th, 2008 - Patients with the clinical diagnosis of hypoglycemia secondary to a putative insulin secreting pancreatic neuroendocrine tumor require accurate localization of the tumor and definitive surgical resection. Non-invasive pre-operative imaging studies...

see more →

News  22 results

More and More U.S. Kids Being Diagnosed With Diabetes
https://www.medpagetoday.com/primarycare/diabetes/94183

Aug 24th, 2021 - Prevalence of type 2 diabetes among American youth has nearly doubled over the past 20 years, a new study found. Since the turn of the century, the estimated prevalence of type 2 diabetes among Americans ages 10 to 19 years increased by a relative...

Current and Emerging Treatments for Gastroenteropancreatic Neuroendocrine Tumors
https://www.onclive.com/view/current-and-emerging-treatments-for-gastroenteropancreatic-neuroendocrine-tumors

Dec 5th, 2020 - Approximately 175,000 Americans are affected by neuroendocrine tumors (NETs), 65% of which are gastroenteropancreatic (GEP) NETs. GEP-NETs represent a diverse family of tumors that arise in the gastrointestinal (GI) tract or pancreas.1-3 The overa...

Mystery hypoglycemia case highlights troublesome diagnosis
https://www.mdedge.com/familymedicine/article/200734/diabetes/mystery-hypoglycemia-case-highlights-troublesome-diagnosis?channel=39313
MDedge Endocrinology; Randy Dotinga

May 11th, 2019 - LOS ANGELES – The 69-year-old woman with a history of type 2 diabetes had persistent hypoglycemia despite treatment with hydrocortisone, dextrose, and glucagon. Doctors in South Carolina worried about insulinoma and planned to launch an intra-arte.

Beta Cell Regeneration; Essure's Afterlife; T2D and Erectile Dysfunction
https://www.medpagetoday.com/endocrinology/generalendocrinology/77073

Dec 21st, 2018 - Researchers at Mount Sinai discovered a combination of two drug classes that yielded the highest proliferation rate of human beta cells. This "makes beta cells regenerate at rates that are suitable for treatment. The next big hurdle is figuring ou...

Clinical Challenges - February 2018 What's your diagnosis?
https://www.mdedge.com/gihepnews/article/157654/clinical-challenges-february-2018-whats-your-diagnosis

Feb 2nd, 2018 - The diagnosis: Metastatic insulinoma surrounded by steatotic hepatocytes The loss of L-FABP expression in steatotic hepatocytes is the hallmark of HNF1alpha-inactivated liver adenoma,1 and clearly suggested this diagnosis. However, the emergence o.

see more →

Patient Education  1 results see all →